GBT Financial Facts
Cost of Goods Sold: 17.93MWeighted average number of common shares outstanding - basic: 76.44M
See Full Income Statement
Total Current Liabilities: 8.14M
Total Liabilities and Stockholders' Equity: 249.66M
See Full Balance Sheet
Global Blood Therapeutics (GBT) Earnings
|
Expand Research on GBT
| Next EPS Date | N/A | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.8% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | -6.7% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2/26/20 |  |
Q419 | -$1.59 | -$1.24 | -$0.35 | N/A | $560K | N/A |  | | Details |
| 11/5/20 | |
Q320 | -$0.97 | -$0.73 | -$0.24 | $36.89M | $43.98M | N/A | | | Details |
| 2/23/22 | |
Q421 | -$1.36 | -$1.13 | -$0.23 | $56.1M | $55.44M | N/A | | | Details |
3/13/17  |
Q416 | -$0.74 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 2/24/21 | |
Q420 | -$1.00 | -$0.94 | -$0.06 | $41.3M | $39.03M | N/A | | | Details |
| 5/1/17 |
Q117 | -$0.60 | N/A | N/A | N/A | N/A | N/A | | | Details | |
| 11/9/16 | Q316 | -$0.58 | -$0.58 | $0.00 | N/A | N/A | N/A | | | Details | |
| 5/4/22 | |
Q122 | -$1.26 | -$1.30 | +$0.04 | $55.16M | $56.14M | N/A | | | Details |
